This wiki has undergone a migration to Confluence found Here
Difference between revisions of "February 4, 2016, Agenda"
Jump to navigation
Jump to search
Hbuitendijk (talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 9: | Line 9: | ||
=Attendees:= | =Attendees:= | ||
| + | * Hans Buitendijk | ||
| + | * Terrie Reed | ||
| + | * Behnaz Minaei | ||
| + | * Ben Moscovittch | ||
| + | * Chris Melo | ||
| + | * Koichiro Matsumoto | ||
| + | * Martha Velezis | ||
| + | * Myron Fynseth | ||
| + | * Scott Brown | ||
| + | * Steve Rosenberg | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
=Meeting Discussion:= | =Meeting Discussion:= | ||
| Line 39: | Line 26: | ||
*Review Call for Participation to ord, devices, pharmacy | *Review Call for Participation to ord, devices, pharmacy | ||
*Review any use cases received, Prioritize | *Review any use cases received, Prioritize | ||
| + | ** Line 8 is considered low priority. Follow-up questions: | ||
| + | *** Do we care about reimbursement number as part of the UDI carrier? | ||
| + | *** Is FDA the right assigning authority, or should it be the issueing agency to ensure implants from US, Brazil, Japan, etc. can be consistently interpreted. | ||
| + | ** Line 9 is considered. Follow-up questions: | ||
| + | *** Would this be just be on the attachment, or in the core of the administrative X12 transaction? | ||
| + | *** Either way, would that be sufficient to feed, or do we need more. | ||
| + | ** X12 items can be used to help justify priority, but do not seem to state specific use cases themselves. | ||
| + | ** We should have a claims submisssion vs. an analytical data collection use case. The first may be of higher priority than the second. | ||
| + | ** Suggest to focus on the core flow first and then on analytical flows (which may result in enrichment of basic capabilities). | ||
*Next Steps Planning | *Next Steps Planning | ||
=Action Items:= | =Action Items:= | ||
*Confirm whether or not the PSS has been approved and submitted to the TSC for approval in time for this Ballot Cycle | *Confirm whether or not the PSS has been approved and submitted to the TSC for approval in time for this Ballot Cycle | ||
| + | ** While submitted mid-December, it did not go out for SSD-SD vote until last Friday. Deadline for votes is Feb 8. Then it will go to TSC. It is also in FMG's queue for approval given potential FHIR involvement / impact. | ||
*Request new listserv for the UDI Use Cases Project (Patrick sent initial email 1/28, followup 2/2) | *Request new listserv for the UDI Use Cases Project (Patrick sent initial email 1/28, followup 2/2) | ||
| + | ** Done. udi@lists.hl7.org | ||
| + | ** Please sign up. | ||
*Confirm that the UDI Task Force will be developing 1) UDI DAM and 2) UDI Implementation Guide (to include harmonization across v2, v3, CDA and FHIR) | *Confirm that the UDI Task Force will be developing 1) UDI DAM and 2) UDI Implementation Guide (to include harmonization across v2, v3, CDA and FHIR) | ||
*Need to spin off a PSS for the C-CDA to address the individual UDI components (this will be a dependency for IG related work) - Request Paul K. update us on this item | *Need to spin off a PSS for the C-CDA to address the individual UDI components (this will be a dependency for IG related work) - Request Paul K. update us on this item | ||
| + | ** Not done yet. | ||
*Identify and Reference all previously related content on this topic (as a resource), for example materials from the UDI Task Force | *Identify and Reference all previously related content on this topic (as a resource), for example materials from the UDI Task Force | ||
| + | ** Available through the PSS. | ||
=Next Meeting:= | =Next Meeting:= | ||
Latest revision as of 16:01, 4 February 2016
Minutes - Universal Device Identifier Use Cases Project Meeting, February 4, 2016
Contents
- Attendees:
- Meeting Discussion:
- Action Items:
- Next Meeting:
Attendees:
- Hans Buitendijk
- Terrie Reed
- Behnaz Minaei
- Ben Moscovittch
- Chris Melo
- Koichiro Matsumoto
- Martha Velezis
- Myron Fynseth
- Scott Brown
- Steve Rosenberg
Meeting Discussion:
- Approve Agenda
- Approve Prior Meeting Minutes, Meeting January 28, 2016
- Review Call for Participation to ord, devices, pharmacy
- Review any use cases received, Prioritize
- Line 8 is considered low priority. Follow-up questions:
- Do we care about reimbursement number as part of the UDI carrier?
- Is FDA the right assigning authority, or should it be the issueing agency to ensure implants from US, Brazil, Japan, etc. can be consistently interpreted.
- Line 9 is considered. Follow-up questions:
- Would this be just be on the attachment, or in the core of the administrative X12 transaction?
- Either way, would that be sufficient to feed, or do we need more.
- X12 items can be used to help justify priority, but do not seem to state specific use cases themselves.
- We should have a claims submisssion vs. an analytical data collection use case. The first may be of higher priority than the second.
- Suggest to focus on the core flow first and then on analytical flows (which may result in enrichment of basic capabilities).
- Line 8 is considered low priority. Follow-up questions:
- Next Steps Planning
Action Items:
- Confirm whether or not the PSS has been approved and submitted to the TSC for approval in time for this Ballot Cycle
- While submitted mid-December, it did not go out for SSD-SD vote until last Friday. Deadline for votes is Feb 8. Then it will go to TSC. It is also in FMG's queue for approval given potential FHIR involvement / impact.
- Request new listserv for the UDI Use Cases Project (Patrick sent initial email 1/28, followup 2/2)
- Done. udi@lists.hl7.org
- Please sign up.
- Confirm that the UDI Task Force will be developing 1) UDI DAM and 2) UDI Implementation Guide (to include harmonization across v2, v3, CDA and FHIR)
- Need to spin off a PSS for the C-CDA to address the individual UDI components (this will be a dependency for IG related work) - Request Paul K. update us on this item
- Not done yet.
- Identify and Reference all previously related content on this topic (as a resource), for example materials from the UDI Task Force
- Available through the PSS.
Next Meeting:
- Thursday, February 11, 2016 at 10:00 AM EST
- Phone: +1 770-657-9270, Passcode: 398652
- WebEx: https://fda.webex.com/fda/j.php?MTID=md9a88ae42bd560327a990e56e1b44f21
